MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    A Novel Dopaminergic Modulator (NDM-101) as an Adjunct to Levodopa: Enhancing Motor Control Without Worsening Dyskinesia in Parkinson’s Disease

    F. Al-Zaidi (Almaty, Kazakhstan)

    Objective: To evaluate the efficacy and safety of NDM-101 as an adjunct to levodopa in reducing OFF-time, improving motor function, and maintaining quality of life…
  • 2025 International Congress

    AI-Driven Prediction Models for Advanced Parkinson’s Disease: A Data-Driven Approach Using PPMI and CDEPA Criteria

    I. Gabilondo, A. Saenz, S. Seijo, A. Ochoa, U. Zalabarria, I. Cuenca, B. Tijero, T. Fernandez, M. Ruiz, M. Acera, J. Gomez, R. Del Pino (Barakaldo, Spain)

    Objective: To develop machine learning models that predict advanced Parkinson’s disease (APD) by integrating quantitative clinical data from the Parkinson’s Progression Markers Initiative (PPMI) with…
  • 2025 International Congress

    Hospitalization Safety in Parkinson’s Disease (PD): Baseline Outcomes Tracked over 1 Year and a Multi-disciplinary Program to Improve Care

    A. Carpentier, H. Martin, M. Musalo, I. Malaty (Montreal, Canada)

    Objective: To report baseline hospitalization outcomes in PD and the development of a comprehensive program for quality improvement. Background: Hospitalization is common in PD and…
  • 2025 International Congress

    Improving Guitar Strumming Mechanics in Parkinson’s Disease: A Case Series Using a Forearm Stabilization Device

    J. Lenger, S. Matsushita, T. Lesiuk, M. Kerulis, N. Punjabi (Miami, USA)

    Objective: This case series aims to explore the potential benefits of a guitar adaptation in enhancing mechanics of guitar strumming among this patient sample. Specifically,…
  • 2025 International Congress

    Noise assessment acoustic measures of sustained vowel in patients with Parkinson’s disease

    I. Khasanov, D. Khasanova (Kazan, Russian Federation)

    Objective: To investigate and quantify the presence of noise in the vocal signals of Parkinson's disease (PD) patients and healthy volunteers (HV) using acoustic measures,…
  • 2025 International Congress

    Advancing the Quality of Life of Parkinson’s Disease (PD) Patients in Ethiopia: The Impact of Self-Management and Coping Skills Training Programs on Patients in a Resource Constrained Settings

    T. Yinesu, Z. Bayu (Addis Ababa, Ethiopia)

    Objective: Evaluating the effectiveness of training in self-management and coping skills for patients with PD Background: The Parkinson’s Patients Support Organization Ethiopia (PPSO-E) implemented a…
  • 2025 International Congress

    Impact of Gastrointestinal Dysfunction Symptoms on Psychomotor Recovery Following 8-Week Aerobic Interval Training in Parkinson’s Disease – Preliminary Results

    K. Lorek, K. Markowska, A. Bereza, E. Koziorowska, S. Budrewicz, P. Nowakowski, S. Chomiak (Wroclaw, Poland)

    Objective: To investigate the impact of gastrointestinal dysfunction symptoms (GIDS) on psychomotor recovery following 8-week aerobic interval training (AIT) in Parkinson's disease (PD). Background: GIDS…
  • 2025 International Congress

    Impact of ND0612 on Levodopa-Induced Dyskinesia in Parkinson’s Disease: Post hoc Analyses From a Randomized, Active-Controlled Study

    A. Ellenbogen, R. Pahwa, J. Hernández-Vara, N. Lopes, J. Pereira, A. Espay (Farmington Hills, USA)

    Objective: To evaluate dyskinesia-related outcomes between optimized subcutaneously administered levodopa/carbidopa (ND0612) + immediate-release levodopa/carbidopa (IR-LD/CD) vs optimized oral IR-LD/CD in patients with Parkinson’s disease (PD).…
  • 2025 International Congress

    Development and Validation of Personal Technology to Treat Hypophonia in Patients with Parkinson’s Disease

    A. Klein, A. Gillespie, D. Anderson, M. Caveney, N. Sundholm (Atlanta, USA)

    Objective: The purpose of this study was to develop and validate wearable technology to improve vocal intensity in patients with Parkinson’s Disease. Background: Parkinson’s disease…
  • 2025 International Congress

    Increased “Off” Time Is Associated With Poorer Clinical and Humanistic Outcomes in Patients With Advancing Parkinson’s Disease: Results From the PROSPECT Observational Study

    P. Sanchez Alonso, D. Houghton, F. Ory-Magne, T. Oeda, D. Safarpour, L. Bergmann, P. Kukreja, K. Onuk, S. Wang, C. Yan, D. Standaert (Majadahonda, Spain)

    Objective: To evaluate the association of increased “Off” time with clinical and humanistic outcomes in people with advanced Parkinson’s disease (PwP) inadequately managed by oral…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley